We came across a bullish thesis on Penumbra, Inc. on stocks subreddit by someroastedbeef. In this article, we will summarize the bulls’ thesis on PEN. Penumbra, Inc.'s share was trading at $357.00 as of January 29th. PEN’s trailing and forward P/E were 85.69 and 69.93 respectively according to Yahoo Finance.
Penumbra (PEN) is a leading medical device company specializing in thrombectomy, where it effectively operates as the market leader with a near-monopoly position. Its proprietary catheter systems and software allow clinicians to distinguish between clot and blood during...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.